Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Gabriella Ferrandina is a leading gynecologic oncologist whose research has fundamentally reshaped surgical approaches to cervical and ovarian cancers. Her work centers on the rigorous evaluation of minimally invasive techniques, particularly robotic surgery, against traditional laparoscopy and open procedures. A landmark 2018 case-matched control study (73 citations) comparing robotic versus laparoscopic radical hysterectomy for early cervical cancer provided crucial evidence on surgical safety and oncologic outcomes. She extended this comparative framework to early ovarian cancer staging (66 citations) and demonstrated the feasibility and safety of robotic surgery in elderly and very elderly patients (58 citations), addressing a critical gap in geriatric oncology. Her prospective Phase II study on robotic radical hysterectomy after chemoradiation for locally advanced cervical cancer (28 citations) pioneered combined-modality surgical strategies. Dr. Ferrandina’s long-term follow-up of minimally invasive staging for early ovarian cancer (52 citations) and her analysis of recurrence patterns between minimally invasive and abdominal radical hysterectomy (25 citations) have provided essential data for surgical decision-making. Through her systematic investigation of robotic aortic lymphadenectomy (17 citations) and comprehensive reviews on surgical management of cervical cancer (8 citations), she has established herself as a key authority on the safe, effective integration of robotic platforms into gynecologic oncology, with her cumulative work cited over 300 times.